Both in Pharmaceuticals
Schrodinger vs Viridian Therapeutics
Over the past year SDGR returned +51.3% and VRDN returned −7.5%; their daily moves had a correlation of 0.12.
SDGR +51.3% VRDN −7.5%Growth of $1, one year, split-adjusted
| Metric | SDGR | VRDN |
|---|---|---|
| Price | $30.33 | $20.00 |
| Market cap | $2.27B | $2.27B |
| Today | +2.81% | −2.80% |
| 1 month | +54.0% | −13.4% |
| 6 months | +174.0% | +7.9% |
| Year to date | +69.6% | −35.7% |
| 1 year | +57.2% | −1.0% |
| Revenue growth (YoY) | +7.5% | +278.7% |
| Gross margin | 55.1% | 100.0% |
| Net margin | 10.1% | −39726.8% |
| P/E (TTM) | — | — |
| Price / sales | 8.8× | 31.8× |
| Net cash | $413.7M | $625.7M |
| Dividend yield | — | — |
| Volatility (60d) | 74.5% | 45.8% |
| Short % of float | 21.3% | 20.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).